Nature’s Sunshine Products (NASDAQ:NATR) Cut to Buy at StockNews.com

StockNews.com lowered shares of Nature’s Sunshine Products (NASDAQ:NATR) from a strong-buy rating to a buy rating in a research note released on Monday.

Separately, DA Davidson dropped their price target on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a buy rating on the stock in a research note on Monday, August 12th.

Nature’s Sunshine Products Trading Down 0.1 %

NATR opened at $13.73 on Monday. The stock has a fifty day moving average price of $14.67 and a 200 day moving average price of $16.58. Nature’s Sunshine Products has a 1 year low of $10.81 and a 1 year high of $21.72. The stock has a market cap of $257.16 million, a price-to-earnings ratio of 16.15 and a beta of 0.87.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.18). The firm had revenue of $110.55 million for the quarter. Nature’s Sunshine Products had a net margin of 3.50% and a return on equity of 9.79%.

Institutional Trading of Nature’s Sunshine Products

Several large investors have recently made changes to their positions in NATR. Jacobs Levy Equity Management Inc. grew its stake in Nature’s Sunshine Products by 1.6% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 58,507 shares of the company’s stock valued at $1,215,000 after buying an additional 927 shares during the last quarter. Lazard Asset Management LLC raised its stake in Nature’s Sunshine Products by 16.5% during the 1st quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock valued at $146,000 after purchasing an additional 998 shares during the last quarter. Gladius Capital Management LP grew its position in Nature’s Sunshine Products by 23.9% in the 2nd quarter. Gladius Capital Management LP now owns 6,862 shares of the company’s stock worth $103,000 after purchasing an additional 1,325 shares during the last quarter. BNP Paribas Financial Markets raised its position in shares of Nature’s Sunshine Products by 12.7% during the first quarter. BNP Paribas Financial Markets now owns 15,207 shares of the company’s stock valued at $316,000 after buying an additional 1,715 shares during the last quarter. Finally, Janney Montgomery Scott LLC grew its position in Nature’s Sunshine Products by 8.9% during the first quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company’s stock worth $523,000 after buying an additional 2,054 shares in the last quarter. Institutional investors own 79.40% of the company’s stock.

About Nature’s Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.